Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.40 |
| ▸ | ATM | Q13315 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | GPR3 | P46089 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 4/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | APAF1 | O14727 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | XBP1 | P17861 | 1/20 | 0.36 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | GALK1 | P51570 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18252532 | 0.97 | L3MBTL1 (0.45) | L3MBTL1ATMKDM4EGPR3MAPT | |
| SCHEMBL18252543 | 0.97 | L3MBTL1 (0.45) | L3MBTL1ATMKDM4EGPR3MAPT | |
| SCHEMBL18252440 | 0.95 | ATM (0.43) | L3MBTL1ATMKDM4EGPR3MAPT | |
| SCHEMBL18252587 | 0.95 | L3MBTL1 (0.47) | L3MBTL1ATMKDM4EGPR3MAPT | |
| SCHEMBL17953841 | 0.92 | L3MBTL1 (0.34) | L3MBTL1ATMKDM4EGPR3MAPT | |
| SCHEMBL20277452 | 0.92 | L3MBTL1 (0.47) | L3MBTL1ATMKDM4EGPR3MAPT | |
| SCHEMBL15630567 | 0.92 | L3MBTL1 (0.47) | L3MBTL1ATMKDM4EGPR3MAPT | |
| SCHEMBL17953820 | 0.90 | ATM (0.38) | L3MBTL1ATMKDM4EKMT2AMEN1 | |
| SCHEMBL17953831 | 0.90 | ATM (0.38) | L3MBTL1ATMKDM4EKMT2AMEN1 | |
| SCHEMBL17953856 | 0.89 | ALOX5 (0.36) | L3MBTL1ATMKDM4EGPR3KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10256411-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-04-09 | — | — | US | disclosed |
| US-20170077409-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-03-16 | — | — | US | disclosed |
| US-20170077409-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-03-16 | — | — | US | disclosed |
| US-20160343951-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-11-24 | — | — | US | disclosed |
| US-20160343951-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160343951-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OSBP, OSBPL3, OSBPL8 | L3MBTL1 953/4885ATM 4208/4885KDM4E 4543/4885 |
| US-20170077409-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OSBP, OSBPL3, OSBPL8 | L3MBTL1 953/4885ATM 4208/4885KDM4E 4543/4885 |
| US-10256411-B2 | Organic electroluminescent materials and devices | OSBP, OSBPL3, OSBPL8 | L3MBTL1 953/4885ATM 4208/4885KDM4E 4543/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.